Article
Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain.
BMC medical genetics - 24 Aug 2020
Huang Fangjin, Tanaka Hisashi, Knudsen Beatrice S, Rutgers Joanne K
Abstract excerpt
BACKGROUND: Mutations in the exonuclease domain of POLE, a DNA polymerase associated with DNA replication and repair, lead to cancers with ultra-high mutation rates. Most studies focus on intestinal and uterine cancers with POLE mutations. These cancers exhibit a significant immune cell infiltrate and favorable prognosis. We questioned whether loss of function of other DNA polymerases can cooperate to POLE to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
